Decarboxylative Alkylation of Alkenes

Why It Matters

The breakthrough provides a universal, functional‑group‑compatible route to highly substituted alkenes, expanding synthetic strategies for pharmaceuticals, agrochemicals and advanced materials.

Key Takeaways

• Polar decarboxylative pathway forms persistent alkylzinc from redox‑active esters.
• Pd‑catalyzed coupling delivers substituted alkenes with high diastereoselectivity.
• Works on terminal, internal, cyclic, and tri‑substituted alkenes.
• Tolerates aldehydes, ketones, alkynes, and diverse functional groups.
• Enables late‑stage alkylation of complex drugs like indomethacin.

Pulse Analysis

Alkene functionalization has long been dominated by electrophilic addition, leaving chemists without a direct substitution analogue comparable to Friedel‑Crafts alkylation for arenes. Traditional routes—Wittig olefination, cross‑metathesis, or radical decarboxylative couplings—are limited by substrate scope, stereocontrol, or the need for pre‑functionalized partners. Consequently, constructing densely substituted alkenes, especially internal or cyclic variants, often requires multistep sequences that erode efficiency and increase waste.

The new polar decarboxylative strategy sidesteps these hurdles by first converting carboxylic acids into redox‑active esters, which, in DMF, are reduced by zinc to form stable alkylzinc species. Simultaneously, alkenes undergo thianthrenation, delivering alkenyl‑thianthrenium electrophiles that engage in a Pd(0)/Pd(II) cross‑coupling cycle. This two‑step sequence proceeds with high regio‑ and diastereoselectivity, delivering E‑alkenes in >20:1 selectivity and tolerating a broad functional‑group landscape—including aldehydes, ketones, and terminal alkynes—without protecting groups. Reported yields range from 52 % for the in‑situ alkylzinc formation to 78 % for the final coupled product, demonstrating practical scalability on 0.2 mmol batches.

For the chemical industry, the ability to directly alkylate alkenes expands the accessible chemical space for drug candidates, agro‑chemicals, and polymer precursors. Late‑stage functionalization of complex molecules such as indomethacin or terpenes becomes feasible, accelerating SAR exploration and reducing synthetic overhead. Moreover, the reliance on inexpensive zinc and palladium catalysts, combined with bench‑stable carboxylic acids, positions the method as a cost‑effective alternative to metal‑mediated radical processes. Future work may extend the scope to tertiary alkyl groups and integrate flow chemistry, further cementing this approach as a cornerstone of modern synthetic design.